Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Trojano

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
European Journal of Neurology|October 15, 2020
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis RegisterV Lepore, C Bosetti, C Santucci, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 20, 2015
A rare case of multiple sclerosis and McArdle diseaseStefano Zoccolella, P Spadafora, C Tortorella, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 25, 2005
Atypical forms of multiple sclerosis or different phases of a same disease?M Trojano, D Paolicelli, A Bellacosa, et al.
Rivista Di Neurologia|May 1, 1987
Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosisP Livrea, I L Simone, M Trojano, et al.
Acta Neurologica|April 1, 1989
[Usefulness of a standardized method for collecting anamnestic data in multiple sclerosis (MS)]M Trojano, C Avolio, F De Robertis, et al.
Journal of Neurology|January 1, 1981
Intrathecal IgG synthesis in multiple sclerosis: comparison between isoelectric focusing and quantitative estimation of cerebrospinal fluid IgGP Livrea, M Trojano, I L Simone, et al.
Journal of Neurology|February 19, 2013
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing studyD Paolicelli, M D'Onghia, F Pellegrini, et al.
Journal of the Neurological Sciences|July 21, 2004
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLINF Patti, M P Amato, M Filippi, et al.
Journal of the Neurological Sciences|November 13, 2012
Lack of information about multiple sclerosis in children can impact parents' sense of competency and satisfaction within the coupleM Messmer Uccelli, S Traversa, M Trojano, et al.
Journal of Neurovirology|June 29, 2000
Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cellsM Trojano, G Defazio, C Avolio, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
European Journal of Neurology|October 15, 2020
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis RegisterV Lepore, C Bosetti, C Santucci, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 20, 2015
A rare case of multiple sclerosis and McArdle diseaseStefano Zoccolella, P Spadafora, C Tortorella, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 25, 2005
Atypical forms of multiple sclerosis or different phases of a same disease?M Trojano, D Paolicelli, A Bellacosa, et al.
Rivista Di Neurologia|May 1, 1987
Cerebrospinal fluid (CSF) parameters and clinical course of multiple sclerosisP Livrea, I L Simone, M Trojano, et al.
Acta Neurologica|April 1, 1989
[Usefulness of a standardized method for collecting anamnestic data in multiple sclerosis (MS)]M Trojano, C Avolio, F De Robertis, et al.
Journal of Neurology|January 1, 1981
Intrathecal IgG synthesis in multiple sclerosis: comparison between isoelectric focusing and quantitative estimation of cerebrospinal fluid IgGP Livrea, M Trojano, I L Simone, et al.
Journal of Neurology|February 19, 2013
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing studyD Paolicelli, M D'Onghia, F Pellegrini, et al.
Journal of the Neurological Sciences|July 21, 2004
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLINF Patti, M P Amato, M Filippi, et al.
Journal of the Neurological Sciences|November 13, 2012
Lack of information about multiple sclerosis in children can impact parents' sense of competency and satisfaction within the coupleM Messmer Uccelli, S Traversa, M Trojano, et al.
Journal of Neurovirology|June 29, 2000
Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cellsM Trojano, G Defazio, C Avolio, et al.
Pageof 11